Ampadu, H. Hilda
Dodoo, Alexander N. O.
Bosomprah, Samuel
Akakpo, Samantha
Hugo, Pierre
Gardarsdottir, Helga
Leufkens, H. G. M.
Kajungu, Dan
Asante, Kwaku Poku
Funding for this research was provided by:
Medicines for Malaria Venture (PO15/00479)
Article History
First Online: 25 April 2018
Compliance with Ethical Standards
:
: H. Hilda Ampadu, Alexander N.O. Dodoo, Samuel Bosomprah, Helga Gardarsdottir, H.G.M. Leufkens, Dan Kajungu and Kwaku Poku Asante have no conflicts of interest. Samantha Akakpo and Pierre Hugo are full-time employees of Medicines for Malaria Venture (MMV).
: Medicines for Malaria Venture provided funding for this study.
: The study received ethical approval from the Ghana Health Service Ethics Review Committee and the Uganda National Council for Science and Technology (UNCST). It was also registered on ClinicalTrials.gov with the ClinicalTrials.gov identifier NCT02817919. The study was conducted under Good Clinical Practice (GCP) guidelines taking into consideration the Declaration of Helsinki (as amended in October 2013) and local rules and regulations of participating countries and health facilities. All personnel involved in the study undertook and successfully passed an online GCP course prior to study initiation unless they already had a valid GCP certificate.
: Written informed consent was obtained from the patients for publication of this study. A copy of the written consent may be requested for review from the corresponding author.
: Consent for publication was obtained as part of the informed consent process.